PD1 Resistance with a Multi-Omic Approach
PharmaTalkRadio10 Maalis 2020

PD1 Resistance with a Multi-Omic Approach

Anti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Danny Wells, Parker Institute for Cancer Immunotherapy will address: Orthogonality and correlation of response biomarkers across histologiesIntegration of multi-omic data sets for mechanistic insights into tumor immunobiologyThe translational approaches to PD1 resistance program at the Parker Institute To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(461)

Suosittua kategoriassa Tiede

utelias-mieli
tiedekulma-podcast
rss-mita-tulisi-tietaa
rss-hereilla
rss-duodecim-lehti
rss-poliisin-mieli
rss-totuuden-liepeilla
rss-kasvatuspsykologiaa-kaikille
rss-tiedetta-vai-tarinaa
koodikahvit
docemilia
rss-ja-ihminen-loi-alyn-aalto-yliopiston-tekoalypodcast